Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2888 Posts
1 2 3 ... 181
Week In Review: Hansoh Signs $1.5 Billion Cross-Border Deal For AI-Drug Discovery With Atomwise
Article By: ChinaBio® Today
Saturday, September 14, 2019 4:53 PM EDT
China's Hansoh Pharma formed an AI-based small molecule drug discovery collaboration worth up to $1.5 billion with Atomwise of San Francisco.
In this article: AZN, CBMG
Read
Aurora Trades Down On Q4 Print, Company Preparing 'Robust Product Lineup' For December Launch In Canada
Article By: Benzinga
Wednesday, September 11, 2019 5:49 PM EDT
Aurora Cannabis Inc ACB narrowly missed its own fourth-quarter net revenue estimate, posting a figure of CA$98.9 million ($74.9 million) after previously guiding to a range of CA$100-$107 million.
In this article: ACB
Read
Japan Drug Firm Bets $3 Billion On Castoffs And Hype
Article By: Lipper Alpha Insight
Monday, September 9, 2019 9:05 PM EDT
The lucrative deal with Sumitomo is just the treatment Roivant needs to keep its model ticking. But it’s unlikely to fix what ails its Japanese partner.
In this article: DNPUF
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
E Portfolio Highlights - September 2019
Article By: Ingrid Hendershot
Monday, September 9, 2019 2:15 PM EDT
During the past three months, the S&P 500 Index rose 2.1% despite renewed concerns over a trade war and slowing global growth. The following high-quality stocks all generated solid 9% or better gains during the same period.
In this article: CNI, JNJ, MA, SYK, UPS, AAPL, FAST, ROST, SBUX, ULTA, BKNG
Read
E Matinas Biopharma Is Highly Undervalued
Article By: Terry Chrisomalis
Monday, September 9, 2019 7:13 AM EDT
With cash concerns put to rest, a solid lead product MAT9001, and a unique lipid nano-crystal delivery technology, I believe Matinas Biopharma is highly undervalued.
In this article: MTNB Also: LGND, XOMA, AMRN, ABUS
Read
Week In Review: PAG Pays $540 Million For 58% Stake In Hisun BioRay, A China Biotech
Article By: ChinaBio® Today
Saturday, September 7, 2019 4:35 PM EDT
PAG, a Hong Kong PE firm, will pay $540 million to acquire a 58% stake in Hisun BioRay, a China biologics company developing autoimmune and oncology drugs.
In this article: AZN, NVS
Read
E CGC: Better Safe Than Sorry
Article By: Christian Stoyanov
Saturday, September 7, 2019 3:52 PM EDT
Recently Canopy Growth Corp. (CGC) has reached its 12 month low, mainly due to excessive cash burns and disappointing results. Even so, I do not find solid underlying company fundamentals for investing in it.
In this article: CGC
Read
E 5 CBD Stock Picks - No Weeds In This Garden
Article By: David Moadel
Thursday, September 5, 2019 10:46 PM EDT
The CBD market is growing by leaps and bounds; here's a prime sampling of cannabidiol stocks to round out your canna-centric holdings.
In this article: CGC, GGBXF, CRON, ACB, CWBHF
Read
E Bellicum Is Worth A Look With Multiple Catalysts On The Way In 2nd Half Of 2019
Article By: Terry Chrisomalis
Thursday, September 5, 2019 8:46 AM EDT
Bellicum is a highly undervalued biotech. Especially, when you consider that it has two types of technology that can be utilized to potentially alter how CAR-T therapies are produced.
In this article: BLCM
Read
The Week Ahead In Biotech: Cardiology, Analyst Conferences In The Spotlight
Article By: Benzinga
Monday, September 2, 2019 3:30 PM EDT
The biotech space saw muted activity in the week ended Aug. 30.
In this article: AZN, JNJ, RHHBY, ALNY, PSTV, AMGN, CELG, MDCO, IONS, AGLE, ANAB, AKCA, ZLAB
Read
The Stock Market Stands On A Precarious Scaffold
Article By: Michele Schneider
Sunday, September 1, 2019 10:15 AM EDT
In the current market, the price action and negative phases in the indices hang precariously. The bulls, nevertheless, continue to trust the scaffolding of low interest rates, hope for a resolution of tariffs and positive economic statistics.
In this article: IBB, QQQ, DIA, IWM, IYT, KRE, SMH, SPY, XRT
Read
Week In Review: HiFiBiO Raises $67 Million For Immune Modulator Portfolio
Article By: ChinaBio® Today
Saturday, August 31, 2019 4:14 PM EDT
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
In this article: LLY
Read
Week In Review: Biotheus Acquires China Rights To Three Bi-specifics In $142 Million Deal
Article By: ChinaBio® Today
Saturday, August 24, 2019 5:15 PM EDT
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
In this article: LLY
Read
E Cannabis Central: How Much Of A Pure Play Is The Pure Cannabis ETF?
Article By: Lorimer Wilson
Tuesday, August 20, 2019 3:42 AM EDT
The AdvisorShares Pure Cannabis ETF debuted this past May as an actively “pure” fund of 28 constituents. Just how pure are the constituents?
In this article: IIPR, YOLO, VFF, HEXO, OGI, CGC, ARNA, ZYNE, ACB, TLRY
Read
Stock Charts To Watch - August 19, 2019
Video By: Harry Boxer
Monday, August 19, 2019 5:14 PM EDT
Amyris, Inc. had a really good session on Monday, jumping 74 cents, or 20%, to 4.41, on 1.5 million shares. Arrowhead Pharmaceuticals, Neogen Corp., Perion Network, SunPower Corp., and XPO Logistics look good as well. Let's take a closer look
In this video: XPO, PERI, AMRS, NEOG, SPWR, ARWR
Watch
1 to 16 of 2888 Posts
1 2 3 ... 181